Musculoskeletal Imaging

What Is the Right Imaging for Osteoporosis Surveillance? An ACR-Guided Workflow

·
What Is the Right Imaging for Osteoporosis Surveillance? An ACR-Guided Workflow

A 68-year-old woman with a history of osteopenia diagnosed two years ago returns to your clinic. She has been diligent with her calcium, vitamin D, and weekly alendronate. Now, the key clinical question arises: is her treatment working? Is her bone mineral density stable, improving, or declining, and has her fracture risk changed? Deciding on the appropriate surveillance imaging is critical for guiding her long-term management. This article provides a detailed workflow for this specific scenario, based on the American College of Radiology (ACR) Appropriateness Criteria. For follow-up imaging of patients with established low bone mineral density, a Dual-energy X-ray Absorptiometry (DXA) scan of the lumbar spine and hip(s) is rated *Usually appropriate*.

Who Fits This Clinical Scenario for Osteoporosis Surveillance?

This guidance is for clinicians managing patients with a previously established diagnosis of low bone mineral density (BMD), such as osteopenia or osteoporosis. The primary goal is surveillance—either monitoring the natural course of the condition or, more commonly, assessing the therapeutic response to pharmacologic interventions (e.g., bisphosphonates, denosumab) or lifestyle modifications. The patient should have a baseline BMD measurement for comparison.

It is crucial to distinguish this follow-up scenario from others:

  • Initial Screening: This workflow does not apply to patients being evaluated for osteoporosis for the first time. A postmenopausal woman with no prior bone density testing, for example, falls into the initial screening category, which has its own distinct recommendations.
  • Younger Patients with Risk Factors: Premenopausal females or males under 50 years of age with specific risk factors (e.g., long-term glucocorticoid use, hypogonadism) represent a separate clinical problem. Their initial workup and follow-up may require different considerations.
  • Patients with Severe Spinal Artifacts: Individuals with advanced degenerative disc disease, scoliosis, extensive aortic calcification, or spinal hardware may have falsely elevated lumbar spine BMD values on DXA. For these patients, alternative imaging sites or techniques may be necessary.

This article focuses exclusively on the routine surveillance of patients already diagnosed and being managed for low BMD.

What Diagnoses Are You Working Up in This Scenario?

When ordering a follow-up bone density scan, you are primarily assessing the trajectory of the patient’s bone health and refining their future fracture risk. The “differential” in this context is less about a new diagnosis and more about determining the patient’s status along a known disease spectrum.

Stable or Improving Bone Mineral Density: This is the desired outcome, particularly in a patient on therapy. A stable or increasing T-score and Z-score suggests an adequate response to treatment. This finding supports continuing the current management plan and provides reassurance regarding the patient’s fracture risk profile.

Progressive Bone Loss (Treatment Failure): A significant decrease in BMD despite therapy is a critical finding. This suggests treatment failure or non-adherence. It prompts a clinical re-evaluation, including a search for secondary causes of osteoporosis that may have been missed, such as hyperparathyroidism, vitamin D deficiency, or malabsorption syndromes. It may also necessitate a change in therapeutic class, for instance, from an antiresorptive agent to an anabolic agent.

Discordant Results: Occasionally, results may be inconsistent between skeletal sites (e.g., spine BMD improves while hip BMD declines). This can be due to technical factors, such as patient positioning, or biological reasons. It requires careful interpretation to understand the patient’s overall fracture risk and may influence decisions about continuing or modifying therapy.

Why Is DXA of the Lumbar Spine and Hip(s) the Recommended Study?

The ACR designates Dual-energy X-ray Absorptiometry (DXA) of the lumbar spine and hip(s) as *Usually appropriate* for osteoporosis surveillance because it is the gold standard for measuring BMD, offering a unique combination of precision, low radiation dose, and extensive validation in clinical trials.

DXA’s high precision is its most important feature for follow-up. It can reliably detect small changes in bone density over time, which is essential for determining if a treatment is effective. The results, reported as T-scores and Z-scores, directly correlate with fracture risk and are the basis for diagnostic criteria from the World Health Organization. The radiation exposure from a DXA scan is minimal, with an effective dose of less than 0.1 mSv, which is significantly lower than a standard chest X-ray and allows for safe, repeated measurements over a patient’s lifetime.

Alternative studies are rated lower for this specific surveillance scenario:

  • Quantitative Computed Tomography (QCT) of the lumbar spine and hip: While QCT can provide a true volumetric BMD and separate trabecular from cortical bone, it is rated *May be appropriate*. Its disadvantages for routine follow-up include a substantially higher radiation dose (1-10 mSv) and lower precision compared to DXA, making it less ideal for tracking changes over time.
  • Quantitative Ultrasound (QUS) of the calcaneus: This modality is rated *Usually not appropriate* for follow-up. Although it is radiation-free and portable, QUS lacks the precision to reliably monitor response to therapy and cannot be used to formally diagnose osteoporosis based on WHO criteria.

When ordering a follow-up DXA, it is critical to request that the scan be performed on the same machine as the prior study to minimize inter-scanner variability. If a vertebral fracture is suspected clinically (e.g., new back pain, height loss), a Vertebral Fracture Assessment (VFA) can be added to the DXA, though VFA alone is *Usually not appropriate* for BMD surveillance. In cases where a new fracture is confirmed and presents with neurologic symptoms, further characterization with other modalities may be warranted. Once you’ve decided on advanced imaging for a complication like a vertebral fracture, our protocol guide can help ensure technical consistency: MRI Lumbar Spine Without Contrast.

What’s Next After DXA? Downstream Workflow

The interpretation of a follow-up DXA scan dictates the next steps in patient management. The report should be compared directly to the prior scan, noting the percentage change in BMD and whether this change exceeds the “least significant change” (LSC), a statistical measure of precision for that specific DXA machine.

  • If BMD is stable or has increased significantly: This result indicates a positive response to therapy. The typical next step is to continue the current treatment regimen. The interval for the next surveillance DXA is generally 2 years, though this can be adjusted based on the patient’s overall clinical picture and fracture risk.
  • If BMD has decreased significantly: This finding signals potential treatment failure or an underlying secondary cause of bone loss. The immediate next step is a clinical re-evaluation. This should include assessing medication adherence, reviewing for new medications that affect bone health (e.g., glucocorticoids), and performing a laboratory workup for secondary causes of osteoporosis (e.g., serum calcium, PTH, 25-hydroxyvitamin D, TSH). A change in therapy may be required.
  • If results are indeterminate or discordant: For example, if the lumbar spine BMD is uninterpretable due to degenerative changes, the hip and forearm sites become more important. A DXA of the distal forearm, rated *May be appropriate*, can be a useful tie-breaker or alternative measurement site. Consultation with an endocrinologist or a specialist in metabolic bone disease may be warranted to help interpret complex results and guide management.

Pitfalls to Avoid (and When to Get Help)

Several common pitfalls can compromise the utility of follow-up DXA scans. First, failing to use the same DXA machine for serial studies introduces variability that can mask real changes or create the illusion of change. Always encourage patients to return to the same imaging center. Second, over-interpreting small changes that are within the scanner’s LSC can lead to unnecessary changes in therapy. Third, ignoring the impact of spinal artifacts like severe degenerative joint disease or aortic calcification can lead to falsely reassuring lumbar spine BMD values. In such cases, rely on the hip or forearm measurements. Finally, scanning too frequently (e.g., annually without a specific high-risk indication) is generally not recommended, as changes are often too small to be reliably detected over short intervals. If you identify a significant, unexpected drop in BMD, escalate by re-evaluating for secondary causes and consider a referral to a bone metabolism specialist.

Related ACR Topics and Tools

This article focuses on a single clinical scenario. For a comprehensive overview of all variants related to bone density imaging, from initial screening to complex presentations, please consult our parent guide. For other clinical questions, the tools below can help you apply evidence-based standards to your practice.

Frequently Asked Questions

How often should a follow-up DXA scan be performed for osteoporosis surveillance?

For most patients on therapy, a follow-up DXA scan every 2 years is considered appropriate. More frequent monitoring (e.g., after 1 year) may be warranted in high-risk patients or after initiating a new therapy, particularly with anabolic agents, to confirm a response. Scanning more frequently than annually is rarely indicated.

What is the ‘least significant change’ (LSC) on a DXA report?

The LSC is a critical quality metric provided by the imaging facility. It represents the smallest change in bone mineral density (BMD) that can be considered statistically significant, rather than just random variation or measurement error. A change in your patient’s BMD must exceed the LSC to be considered a true biological change.

What should I do if the lumbar spine measurement is invalid due to arthritis?

If severe degenerative changes, compression fractures, or surgical hardware make the lumbar spine T-score unreliable, you should rely on the BMD measurements from the hip (total hip and femoral neck). If the hip is also compromised, a DXA of the distal forearm is rated ‘May be appropriate’ and can be ordered as an alternative site for monitoring.

Is Trabecular Bone Score (TBS) useful for follow-up?

Trabecular Bone Score (TBS) is a texture analysis performed on the lumbar spine DXA image that provides information about bone microarchitecture, independent of BMD. While it is rated ‘May be appropriate’ for follow-up, its primary utility is in refining fracture risk at baseline. The role of monitoring changes in TBS over time in response to therapy is still an evolving area of research.

Does my patient need to stop their calcium supplements before a DXA scan?

Yes, it is generally recommended that patients avoid taking calcium supplements for at least 24 hours before their DXA scan. Undissolved calcium tablets in the gastrointestinal tract can be captured in the scan area and artificially increase the measured bone density of the lumbar spine.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 21, 2026